Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in CRPC Post-chemotherapy
NCT01450683Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Sep 2010
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole in castration-resistant prostate cancer (CRPC), sponsored by Stanford University. Started Sep 2010; status: terminated.
02
Drugs
itraconazole
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT01450683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01450683.